Tissue Genesis' Icellator® X Delivers Results in First Clinical Application

Tissue Genesis’ Icellator® X Delivers Results in First Clinical Application

New leading-edge technology produces higher yields of stem cells to enhance patient treatments

HOUSTON, Aug. 21, 2019 /PRNewswire/ — Tissue Genesis, a leading developer of cell therapy processing systems, announced today that an initial group of patients was successfully treated in the first clinical application of its Icellator® X technology at the Okyanos Center for Regenerative Medicine in Freeport, Bahamas. The new fully enclosed and automated system generated a higher yield of stem cells from adipose (fat) tissue than had been previously possible.

Read more